Published in
Elsevier, Seminars in Hematology, 5(60), p. 329-337, 2023
DOI: 10.1053/j.seminhematol.2023.11.007
Links
Tools
CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 